Deciphera Pharmaceuticals, Inc. Investing Cash Flow
Deciphera Pharmaceuticals, Inc. reported Investing Cash Flow of $62.63 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2024-05-10
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was $62.63M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2023-12-31 was $2.20M, a 86.51% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2023-09-30 was $41.40M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for the quarter ending 2023-06-30 was $4.36M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $12.55M.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$34.31M, a 119.40% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2021 was $176.85M, a 521.41% increase from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. net cash provided by (used in) investing activities for fiscal 2020 was $28.46M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2024-03-31 | $62.63M 10-Q · filed 2024-05-10 | $64.83M derived: sum of 2 quarters · filed 2024-05-10 | $106.23M derived: sum of 3 quarters · filed 2024-05-10 | $110.59M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-12-31 | $2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $43.60M derived: sum of 2 quarters · filed 2024-02-07 | $47.96M derived: sum of 3 quarters · filed 2024-02-07 | $12.55M 10-K · filed 2024-02-07 |
| 2023-09-30 | $41.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | $45.76M derived: sum of 2 quarters · filed 2023-10-30 | $10.35M 10-Q · filed 2023-10-30 | $26.65M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-06-30 | $4.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$31.05M 10-Q · filed 2023-08-09 | -$14.75M derived: sum of 3 quarters · filed 2024-05-10 | -$20.82M derived: sum of 4 quarters · filed 2024-05-10 |
| 2023-03-31 | -$35.41M 10-Q · filed 2024-05-10 | -$19.11M derived: sum of 2 quarters · filed 2024-05-10 | -$25.18M derived: sum of 3 quarters · filed 2024-05-10 | -$129.38M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $16.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $10.23M derived: sum of 2 quarters · filed 2024-02-07 | -$93.96M derived: sum of 3 quarters · filed 2024-02-07 | -$34.31M 10-K · filed 2024-02-07 |
| 2022-09-30 | -$6.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-30 | -$110.27M derived: sum of 2 quarters · filed 2023-10-30 | -$50.61M 10-Q · filed 2023-10-30 | $48.34M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -$104.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$44.54M 10-Q · filed 2023-08-09 | $54.41M derived: sum of 3 quarters · filed 2024-02-07 | $68.85M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | $59.65M 10-Q · filed 2023-05-03 | $158.60M derived: sum of 2 quarters · filed 2024-02-07 | $173.04M derived: sum of 3 quarters · filed 2024-02-07 | $112.59M derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | $98.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $113.39M derived: sum of 2 quarters · filed 2024-02-07 | $52.94M derived: sum of 3 quarters · filed 2024-02-07 | $176.85M 10-K · filed 2024-02-07 |
| 2021-09-30 | $14.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$46.01M derived: sum of 2 quarters · filed 2022-11-03 | $77.90M 10-Q · filed 2022-11-03 | $123.97M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-06-30 | -$60.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $63.45M 10-Q · filed 2022-08-04 | $109.53M derived: sum of 3 quarters · filed 2023-02-07 | $111.36M derived: sum of 4 quarters · filed 2023-02-07 |
| 2021-03-31 | $123.91M 10-Q · filed 2022-05-04 | $169.99M derived: sum of 2 quarters · filed 2023-02-07 | $171.81M derived: sum of 3 quarters · filed 2023-02-07 | $154.06M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $46.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $47.90M derived: sum of 2 quarters · filed 2023-02-07 | $30.15M derived: sum of 3 quarters · filed 2023-02-07 | $28.46M 10-K · filed 2023-02-07 |
| 2020-09-30 | $1.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$15.93M derived: sum of 2 quarters · filed 2021-11-02 | -$17.62M 10-Q · filed 2021-11-02 | -$15.94M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | -$17.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$19.44M 10-Q · filed 2021-08-03 | -$17.76M derived: sum of 3 quarters · filed 2022-02-08 | -$312.57M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | -$1.69M 10-Q · filed 2021-05-04 | -$10.00K derived: sum of 2 quarters · filed 2022-02-08 | -$294.82M derived: sum of 3 quarters · filed 2022-02-08 | -$282.56M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | -$293.13M derived: sum of 2 quarters · filed 2022-02-08 | -$280.87M derived: sum of 3 quarters · filed 2022-02-08 | -$460.52M 10-K · filed 2022-02-08 |
| 2019-09-30 | -$294.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$282.55M derived: sum of 2 quarters · filed 2020-11-05 | -$462.20M 10-Q · filed 2020-11-05 | -$462.50M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $12.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$167.39M 10-Q · filed 2020-08-04 | -$167.69M derived: sum of 3 quarters · filed 2021-02-09 | -$167.91M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | -$179.65M 10-Q · filed 2020-05-05 | -$179.95M derived: sum of 2 quarters · filed 2021-02-09 | -$180.17M derived: sum of 3 quarters · filed 2021-02-09 | -$181.69M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | -$303.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | -$519.00K derived: sum of 2 quarters · filed 2021-02-09 | -$2.04M derived: sum of 3 quarters · filed 2021-02-09 | -$2.19M 10-K · filed 2021-02-09 |
| 2018-09-30 | -$216.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$1.74M derived: sum of 2 quarters · filed 2019-11-04 | -$1.89M 10-Q · filed 2019-11-04 | -$2.02M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-06-30 | -$1.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | -$1.68M 10-Q · filed 2019-08-02 | -$1.80M derived: sum of 3 quarters · filed 2020-03-09 | -$2.01M derived: sum of 4 quarters · filed 2020-03-09 |
| 2018-03-31 | -$151.00K 10-Q · filed 2019-05-09 | -$281.00K derived: sum of 2 quarters · filed 2020-03-09 | -$483.00K derived: sum of 3 quarters · filed 2020-03-09 | |
| 2017-12-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$332.00K derived: sum of 2 quarters · filed 2020-03-09 | -$406.00K 10-K · filed 2020-03-09 | |
| 2017-09-30 | -$202.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$276.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | -$74.00K 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | -$223.00K 10-K · filed 2019-03-14 |